Ryvu Therapeutics S.A. announced that it has received 22 million in a round of funding from new investor, European Fund for Strategic Investments, a fund managed by European Investment Bank, Investment Arm on August 17, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55 PLN | +2.61% | +11.11% | -4.35% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.35% | 316M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- RVU Stock
- News Ryvu Therapeutics S.A.
- Ryvu Therapeutics S.A. announced that it has received €22 million in funding from European Investment Bank, Investment Arm